Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTakeda Pharm Or Regulatory News (0RN3)

Share Price Information for Takeda Pharm Or (0RN3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.7143
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 31.568
Low: 30.8925
Yest. Close: 33.7143
0RN3 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Societe Generale SA - Form 8.3 - Takeda Pharmaceutical Co Ltd

Wed, 5th Sep 2018 11:28

RNS Number : 8631Z
Societe Generale SA
05 September 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical CO LTD

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

04/09/2018

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

YES: Shire PLC

 

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,672,360

0.34

6,225,941

0.79

(2) Cash-settled derivatives:

 

5,209,002

0.66

2,026

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

121,500

0.02

0

0.00

 

     TOTAL:

8,002,862

1.02

6,227,967

0.79

           

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

JPY

Ordinary

Purchase

2,400

4635

Ordinary

Purchase

1,000

4619

Ordinary

Purchase

900

4614

Ordinary

Purchase

100

4631

Ordinary

Purchase

100

4592

Ordinary

Purchase

1,000

4598

Ordinary

Purchase

800

4627

Ordinary

Purchase

1,000

4617

Ordinary

Purchase

1,000

4629

Ordinary

Purchase

500

4598

Ordinary

Purchase

1,000

4623

Ordinary

Purchase

1,900

4597

Ordinary

Purchase

1,000

4622

Ordinary

Purchase

1,800

4609

Ordinary

Purchase

800

4610

Ordinary

Purchase

1,000

4602

Ordinary

Purchase

200

4605

Ordinary

Purchase

900

4604

Ordinary

Purchase

500

4617

Ordinary

Purchase

100

4617

Ordinary

Purchase

500

4604

Ordinary

Purchase

1,000

4618

Ordinary

Purchase

1,600

4597

Ordinary

Purchase

100

4591

Ordinary

Purchase

1,000

4593

Ordinary

Purchase

300

4622

Ordinary

Purchase

1,000

4598

Ordinary

Purchase

800

4611

Ordinary

Purchase

300

4601

Ordinary

Purchase

200

4614

Ordinary

Purchase

200

4616

Ordinary

Purchase

1,100

4599

Ordinary

Purchase

1,700

4620

Ordinary

Purchase

200

4620

Ordinary

Purchase

3,800

4635

Ordinary

Purchase

73

4638

Ordinary

Purchase

50

4578

Ordinary

Sale

3,200

4635

Ordinary

Sale

1,900

4617

Ordinary

Sale

700

4635

Ordinary

Sale

300

4607

Ordinary

Sale

100

4617

Ordinary

Sale

200

4635

Ordinary

Sale

300

4609

Ordinary

Sale

100

4619

Ordinary

Sale

200

4615

Ordinary

Sale

500

4603

Ordinary

Sale

600

4602

Ordinary

Sale

100

4597

Ordinary

Sale

500

4599

Ordinary

Sale

1,200

4619

Ordinary

Sale

500

4592

Ordinary

Sale

300

4626

Ordinary

Sale

200

4597

Ordinary

Sale

1,300

4594

Ordinary

Sale

100

4620

Ordinary

Sale

900

4626

Ordinary

Sale

200

4620

Ordinary

Sale

200

4616

Ordinary

Sale

600

4612

Ordinary

Sale

1,500

4627

Ordinary

Sale

1,100

4594

Ordinary

Sale

600

4618

Ordinary

Sale

2,200

4620

Ordinary

Sale

200

4611

Ordinary

Sale

300

4605

Ordinary

Sale

400

4604

Ordinary

Sale

1,100

4620

Ordinary

Sale

500

4620

Ordinary

Sale

500

4601

Ordinary

Sale

700

4597

Ordinary

Sale

1,000

4596

Ordinary

Sale

100

4617

Ordinary

Sale

500

4593

Ordinary

Sale

100

4594

Ordinary

Sale

400

4600

Ordinary

Sale

100

4600

Ordinary

Sale

200

4601

Ordinary

Sale

600

4598

Ordinary

Sale

100

4601

Ordinary

Sale

1,300

4600

Ordinary

Sale

100

4623

Ordinary

Sale

1,200

4615

Ordinary

Sale

200

4600

Ordinary

Sale

100

4599

Ordinary

Sale

100

4614

Ordinary

Sale

100

4604

Ordinary

Sale

800

4604

Ordinary

Sale

400

4604

Ordinary

Sale

200

4602

Ordinary

Sale

1,300

4605

Ordinary

Sale

3,800

4635

Ordinary

Sale

100

4602

Ordinary

Sale

100

4624

Ordinary

Sale

41,950

4610.3147

Ordinary

Sale

148

4653

Total Purchases

31,923

Total Sales

78,298

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit JPY

Ordinary

CFD

Increasing a long position

41,950

4610.3147

 

 (c)       Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit JPY

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit JPY

 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) JPY

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

05/09/2018

Olivier Vero

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1.         KEY INFORMATION

 

Full name of person making disclosure:

SOCIETE GENERALE SA

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Takeda Pharmaceutical CO LTD

 

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

Expiry date

JPY

e.g. American, European etc.

Ordinary

OTC put-option

Sale

15,700

4707

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,000

5075.10

European options

14/12/2018

Ordinary

OTC put-option

Sale

29,600

5073.65

European options

14/12/2018

Ordinary

OTC put-option

Sale

15,500

4491.40

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,700

4533.90

European options

14/12/2018

 

 

 

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETUGUMPBUPRGUA

Login to your account

Don't have an account? Click here to register.